Brind.

Marjorie Soper, who is currently Head of Oncology at Merck, was appointed to the NeoGenomics Board of Directors.

1 report, 0 independent Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Marjorie Soper, who is currently Head of Oncology at Merck, was appointed to the NeoGenomics Board of Directors.

Who's involved

What this event is mainly about
NeoGenomicsMarjorie Soper

Keep exploring

The entities involved

  • NeoGenomics

    cancer genetics diagnostic testing company based in Fort Myers, Florida, USA

    Nothing else this week.

  • Marjorie Soper

    British suffragette and secretary of the National Council for Equal Citizenship

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Unknown outlet